Sanofi Sponsored ADR Forecast, price target & analysts
Sanofi Sponsored ADR Target price 2025 - Analyst rating & recommendation
Sanofi Sponsored ADR Classifications & Recommendation:
Sanofi Sponsored ADR Price Target
| Target Price | $66.17 |
| Price | $47.85 |
| Potential |
38.28%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target Sanofi Sponsored ADR 2026 .
The average Sanofi Sponsored ADR target price is $66.17.
This is
38.28%
register free of charge
$75.22
57.21%
register free of charge
$38.17
20.22%
register free of charge
|
|
| A rating was issued by 29 analysts: 22 Analysts recommend Sanofi Sponsored ADR to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sanofi Sponsored ADR stock has an average upside potential 2026 of
38.28%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 51.91 | 53.67 |
| 6.41% | 3.39% | |
| EBITDA Margin | 23.80% | 31.42% |
| 6.03% | 32.02% | |
| Net Margin | 12.55% | 22.79% |
| 3.24% | 81.52% |
25 Analysts have issued a sales forecast Sanofi Sponsored ADR 2025 . The average Sanofi Sponsored ADR sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Sanofi Sponsored ADR EBITDA forecast 2025. The average Sanofi Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 Sanofi Sponsored ADR Analysts have issued a net profit forecast 2025. The average Sanofi Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 5.18 | 9.76 |
| 2.98% | 88.42% | |
| P/E | 4.91 | |
| EV/Sales | 2.48 |
24 Analysts have issued a Sanofi Sponsored ADR forecast for earnings per share. The average Sanofi Sponsored ADR EPS is
This results in the following potential growth metrics and future valuations:
Sanofi Sponsored ADR...
Current Sanofi Sponsored ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Apr 06 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| LEERINK PARTNERS |
Locked
➜
Locked
|
Locked | Mar 30 2025 |
| HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Apr 07 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Apr 06 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
LEERINK PARTNERS:
Locked
➜
Locked
|
Mar 30 2025 |
|
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Mar 19 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Mar 13 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
